0G token volatility
The company holds 0G as a strategic asset, so fair value changes can materially affect results.
- Scope
- Treasury holdings and listed securities valuation
- Materiality
- high
ZeroStack Corp. is a U.S.-listed company with operations spanning pharmaceutical distribution, cannabis-related consumer products, and a treasury strategy centered on digital assets tied to AI infrastructure. Its operating businesses include the German-based Phatebo wholesale pharmaceutical distributor, the JustCBD consumer brand, cannabis accessories and technology, and other international distribution activities through subsidiaries in the United States, Germany, and Australia.
−431,9 %
4,6 %
−335,6 %
−40,0 %
1.01
0.79
| % | |
|---|---|
| Commercial & Wholesale Pharmaceuticals | 45% Distribution of pharmaceutical goods and medical products through Phatebo and related channels. |
| House of Brands / CBD Consumer Products | 25% Branded hemp- and CBD-based consumer packaged goods sold through retail and specialty channels. |
| Cannabis Accessories & Technology | 15% Consumer accessories and technology products sold under the Vessel brand and related offerings. |
| Cannabis-Infused Beverages | 5% Distribution of cannabis-infused drink products through United Beverage Distribution. |
| AI Treasury / Digital Assets | 10% Strategic ownership and treasury exposure to 0G Tokens and related AI ecosystem assets. |
ZeroStack sells to pharmaceutical wholesalers, healthcare-related buyers, and international distribution partners...
Buy imported and exported pharmaceutical goods for regulated resale and healthcare supply.
Purchase CBD and hemp-derived products for resale in smoke shops, vape shops, clinics, spas, and pet stores.
Buy branded CBD, accessories, and related wellness products through e-commerce and direct channels.
Buy cannabis-infused drinks and related products for regional distribution and retail placement.
Indirect exposure through the 0G treasury strategy and related ecosystem investments.
ZeroStack operates through subsidiaries in the United States, Germany, and Australia, with principal pharmaceutical...
ZeroStack’s stated direction combines an AI-focused treasury strategy with operating businesses that generate cash flow...
The company wants to create value through strategic ownership of AI-linked digital assets.
Pharmaceutical distribution and branded products provide operating revenue outside the treasury strategy.
Broader market access reduces dependence on any single country or regulatory regime.
The company has indicated that inorganic growth can supplement organic expansion.
ZeroStack faces a combination of digital-asset, regulatory, and operating-business risks...
The company holds 0G as a strategic asset, so fair value changes can materially affect results.
Digital assets require secure custody; loss or compromise could permanently reduce holdings.
Product legality, labeling, and distribution rules vary by jurisdiction and can restrict sales.
Wholesale distribution depends on permits, import/export approvals, and local compliance.
Acquisitions and digital-asset operations increase attack surface and integration complexity.
: 29.4.2026